Skip to main content

Table 1 Tolvaptan challenge—response of plasma sodium concentration to tolvaptan therapy

From: Bortezomib-induced hyponatremia: tolvaptan therapy permits continuation of lenalidomide, bortezomib and dexamethasone therapy in relapsed myeloma

Time

09.00

12.00

14.40

18.00

08.00 following day

Plasma Na + (mmol/L)

126

127

130

131

132

Back to article page

Experimental Hematology & Oncology

ISSN: 2162-3619

Contact us